NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/30/2025
Back to search
Official data from USPTO
VOZRIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
05/31/2025
Trademark type
Word
Nice classes
5
Filing date
01/08/2021
Registration date
11/09/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/09/2021
Last transaction
05/31/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
CIANCI, RYAN
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Glaxo Group Limited
Representatives
Legal Brand Protection, GSK
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditionshuman immunodeficiency virus (hiv)human papilloma virusrespiratory syncytial virushepatitisherpes genitalisherpes labialisherpes simplex virusvaricella-zoster virusepstein-barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disordersimmunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disordersautoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of viral conditionshuman immunodeficiency virus (hiv)hpvrsvhepatitisherpes genitalisherpes labialisherpes simplex virusvaricella-zoster virusepstein-barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disordersdisorders of the endocrine systemgrowth and thyroid disordersdiabetesmetabolic syndromeobesityweight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascularcardiopulmonarycardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disordersarthritisrheumatoid arthritisinflammatory bowel diseasesinflammatory connective tissue diseasesvasculitissynovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatmentnausea and vomitinghematologic depressionmucositiscachexiapainbone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disordersthrombocytopeniacoagulation disordersbleeding disordersplatelet disordersblood vessel disorderssickle-cell disease and its related disordersanemiassepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseasesdisorders and injuriesconnective tissue diseasesbone diseasesosteoporosisspinal diseasesback paingoutfracturessprainssports injuriesosteogenesis imperfectamuscle wasting (cachexia)renal osteodystrophycartilage injuriesjoint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disordersdermatitisskin and skin structure infectionsbacterial skin infectionsfungal skin infectionsviral skin infections and parasitic skin infectionspsoriasiseczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disordershypogonadismtestosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disordersirritable bowel disorders and symptomsdigestive disorders and acid-related disorders; pharmaceutical preparations for the treatment of sexual dysfunctionerectile dysfunctionmale and female sexual dysfunction disordersarousal disorderpain disorderdesire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseasesurological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disordersamenorrhoeadysmenorrheal and infertility; pharmaceutical hormonal preparationscorticosteroidshormone replacement therapy preparationsoral contraceptivesthyroid hormone preparations; pharmaceutical preparations for the treatment of incontinenceprostate diseases and disordersbladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseasesinflammatory pelvic diseasesvasomotor/menopausal symptomsendometriosis/uterine fibroidsleiomyomaendourology/stonepre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitisnephritiscystitisvaginitisrenal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorderpremenstrual syndromemale hypogonadism and hormonal disorderspolycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseaseshepatitisnon-alcoholic fatty liver disease (nafld)non-alcoholic steatohepatitis (nash)liver fibroidscirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disordersmood disordersanxiety disorderscognitive disordersschizophreniapsychoses; pharmaceutical preparations for the treatment of damaged skin and tissuebee stingssunburnrashessorescornscalluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines
Publications
History of USPTO decisions and trademark events.
18 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/30/2023
GPNX
NOTIFICATION PROCESSED BY IB
03/12/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/23/2022
FIMP
FINAL DISPOSITION PROCESSED
02/22/2022
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
12/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
11/09/2021
PUBO
PUBLISHED FOR OPPOSITION
08/24/2021
GPNX
NOTIFICATION PROCESSED BY IB
08/22/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/04/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/04/2021
NPUB
NOTICE OF PUBLICATION
08/04/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/20/2021
DOCK
ASSIGNED TO EXAMINER
07/19/2021
MAFR
APPLICATION FILING RECEIPT MAILED
03/19/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/15/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
03/12/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/11/2021
Continuous trademark protection
Get notified about every new filing that threatens VOZRIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.